PFT Global is the renamed clinical trials division of nSpire Health, which iCardiac acquired in July 2015.
iCardiac Technologies, respiratory and cardiac safety studies services provider, unveiled PFT Global, the new name of its respiratory testing service line. The move completes a six-month process of integrating the clinical trials division of nSpire Health, which iCardiac acquired in July 2015.
Read the full release.
Tecentriq Falls Short in Phase III Trial in Post-Surgery Triple-Negative Breast Cancer Patients
February 6th 2025In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve treatment outcomes for patients with high-risk early-stage triple-negative breast cancer.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.